Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN93,4293,48-1,03
Msft-0,06
Nokia5,7285,80,40
IBM0,17
Mercedes-Benz Group AG59,2859,31-0,24
PFE0,24
27.12.2025 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 23.12.2025 21:48:02
China Constrn Bk (0939.F, Frankfurt)
Závěr k 23.12.2025 Změna (%) Změna (EUR) Objem obchodů (EUR)
0,8433 1,08 0,01 4 048
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 28.12.2025
Popis společnosti

Business Summary: CHINA CONSTRUCTION BANK CORPORATION is a commercial bank. The Bank operates its businesses through corporate banking businesses, including corporate deposit, corporate credit loan, asset custody, enterprise annuity, trade financing, international settlement, international financing and value-added services, among others, personal banking businesses, including personal deposit, loan, bank card services, private bank services, foreign exchange trading and gold trading services, among others, and capital business. The Bank operates its businesses in domestic and overseas markets.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, China Construction Bank Corp interest income decreased 8% to RMB867.07B. Net interest income after loan loss provision decreased 8% to RMB305.84B. Net income increased 1% to RMB257.36B. Net interest income after loan loss provision reflects Net Interest Margin, Total -% decrease of 10% to 1.41%. Net Income benefited from Interest expense decrease of 12% to RMB439.46B (expense).



  • Poslední aktualizace: 28.12.2025
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorThomas Lingelbach6120.12.202301.01.2012
Chief Financial OfficerPeter Buehler5520.12.202329.07.2021
Chief Operating OfficerVincent Dequenne5706.07.2021
Chief People OfficerPetra Pesendorfer39
Chief Scientific OfficerHanneke Schuitemaker6103.06.202403.06.2024
General Counsel, Corporate SecretaryKendra Wergin3901.08.202401.08.2024
Chief Business OfficerFranck Grimaud5820.12.202329.11.2002
Chief Medical OfficerJuan Jaramillo5420.12.202301.10.2020
Chief Commercial OfficerDipal Patel5120.12.2023